Research & Development
Scleroderma treatment by Certa Therapeutics granted US FDA fast track
FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
Fasenra could initiate remission in patients with EGPA, study finds
MANDARA Phase III data highlights remission as an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with monthly subcutaneous injections of Fasenra
SGD Pharma awarded 2024 gold EcoVadis rating
SGD Pharma’s sustainability rating of 77 puts the business in the 98th percentile for manufacturers of glass and glass products
Does CBD really harm the liver?
With the exception of certain approved drugs such, as Epidiolex and Sativex, the US Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) have voiced...
Curia appoints Steve Lavezoli as Vice President, Biologics
Curia, a leading contract research, development and manufacturing organisation, has appointed Steve Lavezoli as Vice President of Biologics
Manufacturing Chemist Webinar Roundtables Series - Oral Dosage Manufacturing
5 March 2024 | Webinar | 15:00 GMT
Twist Bioscience puts antibody optimisation potential to use
Partnership to apply antibody optimisation platform to the targeting arm of a bispecific antibody